Synthesis and Bioactivities of Marine Pyran-Isoindolone Derivatives as Potential Antithrombotic Agents

2,5-Bis-[8-(4,8-dimethyl-nona-3,7-dienyl)-5,7-dihydroxy-8-methyl-3-keto-1,2,7,8-teraahydro-6<i>H</i>-pyran[<i>a</i>]isoindol-2-yl]-pentanoic acid (FGFC1) is a marine pyran-isoindolone derivative isolated from a rare marine microorganism <i>Stachybotrys longispora</i&...

Full description

Bibliographic Details
Main Authors: Yinan Wang, Hui Chen, Ruilong Sheng, Zhe Fu, Junting Fan, Wenhui Wu, Qidong Tu, Ruihua Guo
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Marine Drugs
Subjects:
Online Access:https://www.mdpi.com/1660-3397/19/4/218
_version_ 1797537514604462080
author Yinan Wang
Hui Chen
Ruilong Sheng
Zhe Fu
Junting Fan
Wenhui Wu
Qidong Tu
Ruihua Guo
author_facet Yinan Wang
Hui Chen
Ruilong Sheng
Zhe Fu
Junting Fan
Wenhui Wu
Qidong Tu
Ruihua Guo
author_sort Yinan Wang
collection DOAJ
description 2,5-Bis-[8-(4,8-dimethyl-nona-3,7-dienyl)-5,7-dihydroxy-8-methyl-3-keto-1,2,7,8-teraahydro-6<i>H</i>-pyran[<i>a</i>]isoindol-2-yl]-pentanoic acid (FGFC1) is a marine pyran-isoindolone derivative isolated from a rare marine microorganism <i>Stachybotrys longispora</i> FG216, which showed moderate antithrombotic(fibrinolytic) activity. To further enhance its antithrombotic effect, a series of new FGFC1 derivatives (<b>F1</b>–<b>F7</b>) were synthesized via chemical modification at C-2 and C-2′ phenol groups moieties and C-1″ carboxyl group. Their fibrinolytic activities in vitro were evaluated. Among the derivatives, <b>F1</b>–<b>F4</b> and <b>F6</b> showed significant fibrinolytic activities with EC<sub>50</sub> of 59.7, 87.1, 66.6, 82.8, and 42.3 μM, respectively, via enhancement of urokinase activity. Notably, derivative <b>F6</b> presented the most remarkable fibrinolytic activity (2.72-fold than that of FGFC1). Furthermore, the cytotoxicity of derivative <b>F6</b> was tested as well as expression of Fas/Apo-1 and IL-1 on HeLa cells. The results showed that, compared to FGFC1, derivative <b>F6</b> possessed moderate cytotoxicity and apoptotic effect on HeLa cells (statistical significance <i>p</i> > 0.1), making <b>F6</b> a potential antithrombotic agent towards clinical application.
first_indexed 2024-03-10T12:17:12Z
format Article
id doaj.art-48209d54405f41dab58f8065af94043c
institution Directory Open Access Journal
issn 1660-3397
language English
last_indexed 2024-03-10T12:17:12Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series Marine Drugs
spelling doaj.art-48209d54405f41dab58f8065af94043c2023-11-21T15:45:40ZengMDPI AGMarine Drugs1660-33972021-04-0119421810.3390/md19040218Synthesis and Bioactivities of Marine Pyran-Isoindolone Derivatives as Potential Antithrombotic AgentsYinan Wang0Hui Chen1Ruilong Sheng2Zhe Fu3Junting Fan4Wenhui Wu5Qidong Tu6Ruihua Guo7College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, ChinaShanghai Engineering Research Center of Hadal Science and Technology, College of Marine Sciences, Shanghai Ocean University, Shanghai 201306, ChinaCQM-Centro de Química da Madeira, Campus da Penteada, Universidade da Madeira, 9000-390 Funchal, PortugalCollege of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, ChinaSchool of Pharmacy, Nanjing Medical University, Nanjing 211166, ChinaCollege of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, ChinaSchool of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013, ChinaCollege of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China2,5-Bis-[8-(4,8-dimethyl-nona-3,7-dienyl)-5,7-dihydroxy-8-methyl-3-keto-1,2,7,8-teraahydro-6<i>H</i>-pyran[<i>a</i>]isoindol-2-yl]-pentanoic acid (FGFC1) is a marine pyran-isoindolone derivative isolated from a rare marine microorganism <i>Stachybotrys longispora</i> FG216, which showed moderate antithrombotic(fibrinolytic) activity. To further enhance its antithrombotic effect, a series of new FGFC1 derivatives (<b>F1</b>–<b>F7</b>) were synthesized via chemical modification at C-2 and C-2′ phenol groups moieties and C-1″ carboxyl group. Their fibrinolytic activities in vitro were evaluated. Among the derivatives, <b>F1</b>–<b>F4</b> and <b>F6</b> showed significant fibrinolytic activities with EC<sub>50</sub> of 59.7, 87.1, 66.6, 82.8, and 42.3 μM, respectively, via enhancement of urokinase activity. Notably, derivative <b>F6</b> presented the most remarkable fibrinolytic activity (2.72-fold than that of FGFC1). Furthermore, the cytotoxicity of derivative <b>F6</b> was tested as well as expression of Fas/Apo-1 and IL-1 on HeLa cells. The results showed that, compared to FGFC1, derivative <b>F6</b> possessed moderate cytotoxicity and apoptotic effect on HeLa cells (statistical significance <i>p</i> > 0.1), making <b>F6</b> a potential antithrombotic agent towards clinical application.https://www.mdpi.com/1660-3397/19/4/218pyran-isoindolone derivativesantithrombotic agentsfibrinolytic activityPro-uPA-catalyzed plasminogenmodification
spellingShingle Yinan Wang
Hui Chen
Ruilong Sheng
Zhe Fu
Junting Fan
Wenhui Wu
Qidong Tu
Ruihua Guo
Synthesis and Bioactivities of Marine Pyran-Isoindolone Derivatives as Potential Antithrombotic Agents
Marine Drugs
pyran-isoindolone derivatives
antithrombotic agents
fibrinolytic activity
Pro-uPA-catalyzed plasminogen
modification
title Synthesis and Bioactivities of Marine Pyran-Isoindolone Derivatives as Potential Antithrombotic Agents
title_full Synthesis and Bioactivities of Marine Pyran-Isoindolone Derivatives as Potential Antithrombotic Agents
title_fullStr Synthesis and Bioactivities of Marine Pyran-Isoindolone Derivatives as Potential Antithrombotic Agents
title_full_unstemmed Synthesis and Bioactivities of Marine Pyran-Isoindolone Derivatives as Potential Antithrombotic Agents
title_short Synthesis and Bioactivities of Marine Pyran-Isoindolone Derivatives as Potential Antithrombotic Agents
title_sort synthesis and bioactivities of marine pyran isoindolone derivatives as potential antithrombotic agents
topic pyran-isoindolone derivatives
antithrombotic agents
fibrinolytic activity
Pro-uPA-catalyzed plasminogen
modification
url https://www.mdpi.com/1660-3397/19/4/218
work_keys_str_mv AT yinanwang synthesisandbioactivitiesofmarinepyranisoindolonederivativesaspotentialantithromboticagents
AT huichen synthesisandbioactivitiesofmarinepyranisoindolonederivativesaspotentialantithromboticagents
AT ruilongsheng synthesisandbioactivitiesofmarinepyranisoindolonederivativesaspotentialantithromboticagents
AT zhefu synthesisandbioactivitiesofmarinepyranisoindolonederivativesaspotentialantithromboticagents
AT juntingfan synthesisandbioactivitiesofmarinepyranisoindolonederivativesaspotentialantithromboticagents
AT wenhuiwu synthesisandbioactivitiesofmarinepyranisoindolonederivativesaspotentialantithromboticagents
AT qidongtu synthesisandbioactivitiesofmarinepyranisoindolonederivativesaspotentialantithromboticagents
AT ruihuaguo synthesisandbioactivitiesofmarinepyranisoindolonederivativesaspotentialantithromboticagents